Highlights of the Biology and Disease-driven Human Proteome Project, 2015-2016.

The Biology and Disease-driven Human Proteome Project (B/D-HPP) is aimed at supporting and enhancing the broad use of state-of-the-art proteomic methods to characterize and quantify proteins for in-depth understanding of the molecular mechanisms of biological processes and human disease. Based on a foundation of the pre-existing HUPO initiatives begun in 2002, the B/D-HPP is designed to provide standardized methods and resources for mass spectrometry and specific protein affinity reagents and facilitate accessibility of these resources to the broader life sciences research and clinical communities. Currently there are 22 B/D-HPP initiatives and 3 closely related HPP resource pillars. The B/D-HPP groups are working to define sets of protein targets that are highly relevant to each particular field to deliver relevant assays for the measurement of these selected targets and to disseminate and make publicly accessible the information and tools generated. Major developments are the 2016 publications of the Human SRM Atlas and of "popular protein sets" for six organ systems. Here we present the current activities and plans of the BD-HPP initiatives as highlighted in numerous B/D-HPP workshops at the 14th annual HUPO 2015 World Congress of Proteomics in Vancouver, Canada.

[1]  Matej Oresic,et al.  Data standards can boost metabolomics research, and if there is a will, there is a way , 2015, Metabolomics.

[2]  David D. Shteynberg,et al.  Opening a SWATH Window on Posttranslational Modifications: Automated Pursuit of Modified Peptides* , 2015, Molecular & Cellular Proteomics.

[3]  Eric W Deutsch,et al.  State of the human proteome in 2013 as viewed through PeptideAtlas: comparing the kidney, urine, and plasma proteomes for the biology- and disease-driven Human Proteome Project. , 2014, Journal of proteome research.

[4]  Martin Eisenacher,et al.  Development of data representation standards by the human proteome organization proteomics standards initiative , 2015, J. Am. Medical Informatics Assoc..

[5]  Lennart Martens,et al.  Human Proteome Project Mass Spectrometry Data Interpretation Guidelines 2.1. , 2016, Journal of proteome research.

[6]  L. Ferrucci,et al.  Priorities and trends in the study of proteins in eye research, 1924–2014 , 2015, Proteomics. Clinical applications.

[7]  F. Corrales,et al.  Methylthioadenosine (MTA) Regulates Liver Cells Proteome and Methylproteome: Implications in Liver Biology and Disease* , 2016, Molecular & Cellular Proteomics.

[8]  A. Nesvizhskii,et al.  Metrics for the Human Proteome Project 2015: Progress on the Human Proteome and Guidelines for High-Confidence Protein Identification. , 2015, Journal of proteome research.

[9]  Cathy H. Wu,et al.  The Human Proteome Project: Current State and Future Direction , 2011, Molecular & Cellular Proteomics.

[10]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[11]  Christoph H Borchers,et al.  A Human Proteome Detection and Quantitation Project* , 2009, Molecular & Cellular Proteomics.

[12]  Gary D Bader,et al.  A draft map of the human proteome , 2014, Nature.

[13]  Gary D Bader,et al.  The human genome and drug discovery after a decade. Roads (still) not taken , 2011, 1102.0448.

[14]  Yuri A. Mirokhin,et al.  A Description of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) Common Data Analysis Pipeline. , 2016, Journal of proteome research.

[15]  Chris Sander,et al.  Human SRMAtlas: A Resource of Targeted Assays to Quantify the Complete Human Proteome , 2016, Cell.

[16]  Lydie Lane,et al.  Metrics for the Human Proteome Project 2016: Progress on Identifying and Characterizing the Human Proteome, Including Post-Translational Modifications. , 2016, Journal of proteome research.

[17]  Nigel W. Hardy,et al.  Meeting Report from the Second “Minimum Information for Biological and Biomedical Investigations” (MIBBI) workshop , 2010, Standards in genomic sciences.

[18]  F. He,et al.  Transcriptome and proteome of human hepatocellular carcinoma reveal shared metastatic pathways with significant genes , 2015, Proteomics.

[19]  Conrad Bessant,et al.  Galaxy Integrated Omics: Web-based Standards-Compliant Workflows for Proteomics Informed by Transcriptomics* , 2015, Molecular & Cellular Proteomics.

[20]  B. Kuster,et al.  Mass-spectrometry-based draft of the human proteome , 2014, Nature.

[21]  Huaizhong Zhang,et al.  The mzqLibrary – An open source Java library supporting the HUPO‐PSI quantitative proteomics standard , 2015, Proteomics.

[22]  S. Carr,et al.  Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry , 2013, Nature Methods.

[23]  Andrew I Su,et al.  Data-Driven Approach To Determine Popular Proteins for Targeted Proteomics Translation of Six Organ Systems. , 2016, Journal of proteome research.

[24]  Juan Antonio Vizcaíno,et al.  ms-data-core-api: an open-source, metadata-oriented library for computational proteomics , 2015, Bioinform..

[25]  Martin Eisenacher,et al.  PRIDE Inspector Toolsuite: Moving Toward a Universal Visualization Tool for Proteomics Data Standard Formats and Quality Assessment of ProteomeXchange Datasets , 2015, Molecular & Cellular Proteomics.

[26]  Ioannis Xenarios,et al.  The Human Diabetes Proteome Project (HDPP): The 2014 update , 2015 .

[27]  Andrew I Su,et al.  Prioritizing Proteomics Assay Development for Clinical Translation. , 2015, Journal of the American College of Cardiology.

[28]  J. Enghild,et al.  Proteomics and the Eye , 2014, Proteomics. Clinical applications.

[29]  Fredrik Levander,et al.  Representation of selected-reaction monitoring data in the mzQuantML data standard , 2015, Proteomics.

[30]  Ruedi Aebersold,et al.  A Mass Spectrometric-Derived Cell Surface Protein Atlas , 2015, PloS one.